ProstaLund AB (publ) (PLUN.ST)
ProstaLund AB (publ) operates in the Medical - Care Facilities industry of the Healthcare sector, headquartered in Lund, SE. The stock last traded at $0.21, down 35.15% on the session, giving a market capitalisation of $775,547. Its beta of 0.26 implies it has historically moved less than the broad market.
ProstaLund AB (publ) specializes in the creation and distribution of urological medical devices, primarily targeting patients with benign prostatic hyperplasia (BPH) in Sweden and across global markets. Their product offerings include CoreTherm, a thermal treatment method for BPH, and Gepan instill, designed for addressing chronic bladder inflammation. These solutions are utilized in hospitals and various clinical settings. Established in 1991, the company is based in Lund, Sweden, and operates as a subsidiary of Farstorps Gard Forvaltnings AB.
ProstaLund AB (publ) is most often compared with the following Healthcare names: